Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Guideline on Preventing VTE in Pediatric Cancer

J Thromb Haemost; ePub 2017 Nov 27; Tullius, et al

The International Society on Thrombosis and Hemostasis has released guidance on identifying at-risk patients and preventing venous thromboembolism in pediatric cancer. Among the recommendations:

  • Perform comprehensive risk assessment on each pediatric cancer patient at the initiation of cancer therapy.
  • Do not administer routine primary thromboprophylaxis in pediatric cancer patients without a history of prior thrombosis.
  • Administer thromboprophylaxis in pediatric cancer patients with prior thrombosis who are continuing to receive intensive therapy, as long as there are no anticoagulation contraindications.
  • Consider thromboprophylaxis on a case-by-case basis for pediatric cancer patients with no history of VTE, but with significant combinations of risk factors, including central venous catheters, asparaginase therapy, obesity, adolescence, hormonal contraceptives, or hospitalization for surgery.

Citation:

Tullius B, Athale U, van Ommen C, Chan A, Palumbo J, Balagtas J. The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: Guidance from the SSC of the ISTH. [Published online ahead of print November 27, 2017]. J Thromb Haemost. doi:10.1111/jth.13895.

This Week's Must Reads

Intensity modulated radiation therapy may be preferable in children with extremity nonrhabdomyosarcoma soft-tissue sarcomas, Source: Rao A et al. Intl J Rad Oncology*Biology*Physics; Jan. 2019, 38-44. https://doi.org/10.1016/j.ijrobp.2018.09.005

Thrombolysis for acute ischemic stroke safe in GI malignancy, Inohara T et al. Circulation. 2018 Nov 6;138[suppl 1], Abstract A12291

Ten years of anastrozole boosts disease-free survival, Ohtani S et al. SABCS 2018, Abstract GS3-04

TAO: Nonwhite ethnicity, limb infection predict poor prognosis, Le Joncour A et al. Arthritis Rheumatol. 2018;70(Suppl 10): Abstract 1885

Must Reads in Bleeding Disorders

FDA draft guidance on platelet safety, FDA Draft Guidance, December 2018

HemoTypeSC offers rapid sickle cell detection, Serrao E et al. ASH 2018, Abstract LBA-3

Impact of RBC transfusion limits, Roubinian NH et al. Ann Intern Med. 2018 Dec 18. doi: 10.7326/M17-3253

Early results for novel hemophilia A infusion, Chowdary P et al. ASH 2018, Abstract 489

Diagnostic challenges in hemophilia A, Patil R et al. Thromb Res. 2018 Dec;172:29-35